TreeFrog Therapeutics is a French biotech innovator developing industrial-scale platforms to produce stem cells for regenerative medicine. Its core C-Stem technology uses microfluidic encapsulation to grow 3D stem-cell microtissues at unprecedented scale[1][2]. For example, in 2021 TreeFrog reported a record batch of 15 billion pluripotent stem cells gr…
© 2026 Defence Finance Monitor · Privacy ∙ Terms ∙ Collection notice
Substack is the home for great culture


